| Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor KH Grabstein, J Eisenman, K Shanebeck, C Rauch, S Srinivasan, V Fung, ... Science 264 (5161), 965-968, 1994 | 1953 | 1994 |
| Utilization of the beta and gamma chains of the IL‐2 receptor by the novel cytokine IL‐15. JG Giri, M Ahdieh, J Eisenman, K Shanebeck, K Grabstein, S Kumaki, ... The EMBO journal 13 (12), 2822-2830, 1994 | 1296 | 1994 |
| Interleukin 1 signaling occurs exclusively via the type I receptor. JE Sims, MA Gayle, JL Slack, MR Alderson, TA Bird, JG Giri, F Colotta, ... Proceedings of the National Academy of Sciences 90 (13), 6155-6159, 1993 | 827 | 1993 |
| Identification and cloning of a novel IL‐15 binding protein that is structurally related to the alpha chain of the IL‐2 receptor. JG Giri, S Kumaki, M Ahdieh, DJ Friend, A Loomis, K Shanebeck, ... The EMBO journal 14 (15), 3654-3663, 1995 | 775 | 1995 |
| Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma. SG Reed, CF Nathan, DL Pihl, P Rodricks, K Shanebeck, PJ Conlon, ... The Journal of experimental medicine 166 (6), 1734-1746, 1987 | 283 | 1987 |
| Purification to homogeneity of B cell stimulating factor. A molecule that stimulates proliferation of multiple lymphokine-dependent cell lines. K Grabstein, J Eisenman, D Mochizuki, K Shanebeck, P Conlon, T Hopp, ... The Journal of experimental medicine 163 (6), 1405-1414, 1986 | 223 | 1986 |
| Induction of B cell costimulatory function by recombinant murine CD40 ligand MK Kennedy, KM Mohler, KD Shanebeck, PR Baum, KS Picha, ... European journal of immunology 24 (1), 116-123, 1994 | 200 | 1994 |
| Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. JG Giri, J Wells, SK Dower, CE McCall, RN Guzman, J Slack, TA Bird, ... Journal of Immunology (Baltimore, Md.: 1950) 153 (12), 5802-5809, 1994 | 195 | 1994 |
| Interleukin‐12 regulates the proliferation of Th1, but not Th2 or Th0, clones MK Kennedy, KS Picha, KD Shanebeck, DM Anderson, KH Grabstein European journal of immunology 24 (10), 2271-2278, 1994 | 163 | 1994 |
| Genetically encoded azide containing amino acid in mammalian cells enables site-specific antibody–drug conjugates using click cycloaddition chemistry MP VanBrunt, K Shanebeck, Z Caldwell, J Johnson, P Thompson, ... Bioconjugate chemistry 26 (11), 2249-2260, 2015 | 152 | 2015 |
| Regulation of T cell proliferation by IL-7. KH Grabstein, AE Namen, K Shanebeck, RF Voice, SG Reed, MB Widmer Journal of immunology (Baltimore, Md.: 1950) 144 (8), 3015-3020, 1990 | 152 | 1990 |
| Regulation of murine B cell growth and differentiation by CD30 ligand KD Shanebeck, CR Maliszewski, MK Kennedy, KS Picha, CA Smith, ... European journal of immunology 25 (8), 2147-2153, 1995 | 137 | 1995 |
| The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2. KH Grabstein, CR Maliszewski, K Shanebeck, TA Sato, MK Spriggs, ... Journal of immunology (Baltimore, Md.: 1950) 150 (8), 3141-3147, 1993 | 132 | 1993 |
| Variable expression of immunoreactive surface proteins of Propionibacterium acnes MJ Lodes, H Secrist, DR Benson, S Jen, KD Shanebeck, J Guderian, ... Microbiology 152 (12), 3667-3681, 2006 | 98 | 2006 |
| IFN-γis a potent inducer of Ig secretion by sort-purified murine B cella activated through the mlg, but not the CD40, signaling pathway CM Snapper, F Rosas, MA Moorman, L Jin, K Shanebeck, DM Klinman, ... International immunology 8 (6), 877-885, 1996 | 51 | 1996 |
| Development of copper-catalyzed azide–alkyne cycloaddition for increased in vivo efficacy of interferon β-1b by site-specific PEGylation NW Nairn, KD Shanebeck, A Wang, TJ Graddis, MP VanBrunt, ... Bioconjugate Chemistry 23 (10), 2087-2097, 2012 | 45 | 2012 |
| Antibody derivatives K Grabstein, W Brady, G King, NW Nairn, KD Shanebeck, PH Slagle, ... US Patent App. 13/791,312, 2014 | 39 | 2014 |
| Fusion Protein Comprising Leptin and Methods for Producing and Using the Same Y Lu, J Lu, L Yang, L Li, K Shanebeck, L Liu US Patent App. 15/644,764, 2018 | 24 | 2018 |
| AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use—improves psoriasis in a human xenograft transplantation model K Stenderup, C Rosada, K Shanebeck, W Brady, MP Van Brunt, G King, ... Protein Engineering, Design and Selection 28 (10), 467-480, 2015 | 15 | 2015 |
| Induction of macrophage microbicidal activity by granulocyte-macrophage colony stimulating factor (GM-CSF) K Grabstein, S Reed, K Shanebeck, P Morrissey LYMPHOKINE RESEARCH 6 (1), U127-U127, 1987 | 10 | 1987 |
